chevron_leftBack
As of 14 June 2026, Zhejiang Shengda Bio-Pharm Co., Ltd. has a market cap of $444.42M USD, ranking #15946 globally and #5002 in China.
It ranks #1426 in the Healthcare sector, and #518 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$444.42MUSD
3.01B CNY
Enterprise Value
$410.11MUSD
2.78B CNY
Revenue (TTM)
$122.57MUSD
830.53M CNY
EBITDA (TTM)
$22.34MUSD
151.17M CNY
Net Income (TTM)
$7.91MUSD
53.62M CNY
EBITDA Margin
18%
Profit Margin
6.5%
PE Ratio
54.9
PS Ratio
3.6
PB Ratio
1.8
EV/EBITDA
18.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Bin Zhou
open_in_new
Employees
1,035
Founded
1999
Website
sd-pharm.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.8% | -3.8% | -6.2% | -21% | -13% | -6.1% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
603079
浙江圣达生物药业股份有限公司 Class A
ISIN: CNE100002W43
Shares Out.:
Shares Outstanding:
187.438M1
Shares Float:
143.79M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
15.96 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Zhejiang Shengda Bio-Pharm Co., Ltd.
Zhejiang Shengda Bio-Pharm Co., Ltd. develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry. It offers vitamins, such as biotin and folic acid; biological preservatives, including nisin, polylysine, and natamycin; and intermediate APIs. The company was incorporated in 1999 and is headquartered in Tiantai, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
12K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
11K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
6K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
4K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
4K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
4K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
171K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
123K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
81K%
|
97.4
|
|
SIX: RO
|
$321.52B
72K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
65K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
62K%
218.9B CHF
|
20.5
|
chevron_leftBack